Zymeworks (ZYME) Enterprise Value (2021 - 2026)

Zymeworks has disclosed Enterprise Value across 6 years of filings, most recently posting -$364.7 million for Q1 2026.

• Enterprise Value for Q1 2026 came in at -$364.7 million, down 37.48% year-over-year; the trailing twelve-month figure through Mar 2026 was -$364.7 million (down 37.48% YoY), and the FY2025 annual result was -$228.8 million, down 1.34% from the prior year.
• Enterprise Value came in at -$364.7 million for Q1 2026 at Zymeworks, down from -$228.8 million in the prior quarter.
• In the past five years, Enterprise Value ranged from a high of -$166.2 million in Q3 2022 to a low of -$492.2 million in Q4 2022.
• The 5-year median for Enterprise Value is -$297.2 million (2024), against an average of -$306.6 million.
• Across the five-year window, Enterprise Value plunged 94.86% in 2022 and surged 39.68% in 2024, its largest moves.
• Zymeworks' Enterprise Value stood at -$492.2 million in 2022, then gained by 23.95% to -$374.3 million in 2023, then jumped by 39.68% to -$225.8 million in 2024, then declined by 1.34% to -$228.8 million in 2025, then plunged by 59.41% to -$364.7 million in 2026.
• The last three Enterprise Value figures came in at -$364.7 million (Q1 2026), -$228.8 million (Q4 2025), and -$251.9 million (Q3 2025), per Business Quant data.